Virginia Board of Medicine Practitioner Information

Home Icon Home

Search Icon Search

Disclaimer Icon Disclaimers

Links Icon Links

Glossary Icon Glossary

Help Icon Questions


Printer Friendly Version Printer Icon
 

Matthew William Sherwood, MD

LICENSE # 0101260144
  0101260144

Issue Date: 5/3/2016
Expiration Date: 5/31/2026
Status: Current Active


General InformationEducationCertifications & Practice AreaInsuranceHonors & AwardsAcademic Appointments & PublicationsProceedings, Actions & ConvictionsPaid Claims
Unless otherwise indicated, this information has been self-reported and has not been verified by the Board of Medicine.


Academic Appointments
Last Updated 5/7/2024
Duke University School Of Medicine - Durham NC
Rank: Assistant Professor
Years: 2015-Present

Duke University School Of Medicine - Durham NC
Rank: Assistant Professor
Years: 2016-Present

University Of Virginia School Of Medicine - Charlottesville VA
Rank: Assistant Professor
Years: 2021-Pres

Academic Appointments - Non-US
Last Updated 5/7/2024
None Reported
Publications
(up to ten in the last five years)
Last Updated 5/7/2024
Acute coronary syndromes: Blood transfusion in patients with acute MI and anaemia
Nature Reviews in Cardiology
Nat Rev Cardiol. 2013 Apr;10(4):186-7.
Date: 04 2013
www.nature.com/nrcardio/journal/v10/n4/full/nrcardio.2013.14.html

High-sensitivity troponin assays: evidence, indications, and reasonable use
Journal of the American Heart Association
J Am Heart Assoc. 2014 Jan 27;3(1):e000403
Date: 11 2013
jaha.ahajournals.org/content/3/1/e000403.long

Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry
Journal of the American Heart Association
J Am Heart Assoc. 2014 Apr 14;3(2):e000849
Date: 01 2014
jaha.ahajournals.org/content/3/2/e000849.long

Patterns of Red Blood Cell Transfusion in Patients Undergoing Percutaneous Coronary Intervention.
Journal of the American Medical Association
JAMA. 2014;311(8):836-843
Date: 02 2014
jama.jamanetwork.com/article.aspx?articleid=1832543

Outcomes of Temporary Interruption of Rivaroxaban Compared With Warfarin in Patients With Nonvalvular Atrial Fibrillation: The ROCKET AF Trial
Circulation
Circulation. 2014;129:1850-1859
Date: 05 2014
circ.ahajournals.org/content/129/18/1850

Revascularization in stable coronary artery disease
Journal of the American Medical Association
JAMA. 2014 Nov 19;312(19):2028-9.
Date: 11 2014
jama.jamanetwork.com/article.aspx?articleid=1935107

The Impact of Extreme-Risk Cases on Hospitals’ Risk-Adjusted PCI Mortality Ratings
JACC Cardiovascular Interventions
J Am Coll Cardiol Intv. 2015; 8(1_PA):10-16.
Date: 01 2015
interventions.onlinejacc.org/article.aspx?articleid=2022363&resultClick=3

Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review
Journal of the American Heart Association
J Am Heart Assoc. 2015 Oct 29;4(11). pii: e002245.
Date: 10 2015
jaha.ahajournals.org/content/4/11/e002245.long

Gastrointestinal Bleeding in Patients With Atrial Fibrillation Treated With Rivaroxaban or Warfarin ROCKET AF Trial
Journal of the American College of Cardiology
J Am Coll Cardiol. 2015;66(21):2271-2281
Date: 12 2015
content.onlinejacc.org/article.aspx?articleid=2472843&resultClick=3

Use of Dual Antiplatelet Therapy and Patient Outcomes in Those Undergoing Percutaneous Coronary Intervention: The ROCKET AF Trial
JACC Cardiovascular Interventions
J Am Coll Cardiol Intv. 2016;9(16):1694-1702.
Date: 08 2016
interventions.onlinejacc.org/article.aspx?articleid=2544546&resultClick=3